ENOXAPARIN Side Effects

6765080-7 | Abdominal Wall Haematoma
on Jun 09, 2010 Male patient from UNITED STATES , 55 years of age, weighting 110.0 lb, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Enoxaparin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal wall haematoma. Enoxaparin dosage: 100 Mg Bid Sq. During the same period patient was treated with WARFARIN (5 Mg Every Day Po) (View Warfarin Review and Warfarin Label ). Patient was hospitalized.

6428704-X | Haematuria
Patient was taking Enoxaparin (View Usage). Patient had the following side effects: haematuria on Nov 04, 2009 from UNITED STATES Additional patient health information: Male patient , 79 years of age, weighting 143.3 lb, was diagnosed with deep vein thrombosis (What is deep vein thrombosis?), rectal cancer stage iv and. Enoxaparin dosage: 100 Mg Every Day Sq. During the same period patient was treated with BEVACIZUMAB (350 Mg Other Iv) (View Bevacizumab Review and Bevacizumab Label ).

6426772-2 | Haemorrhage, Renal Failure Acute, Retroperitoneal Haematoma
Adverse event was reported on Nov 03, 2009 by a Male patient taking Enoxaparin (View Usage) (Dosage: 145 Mg Bid Sq) was diagnosed with pulmonary embolism (What is pulmonary embolism?) and. Location: UNITED STATES , 66 years of age, weighting 145.0 lb, After Enoxaparin was administered, patient had the following side effects: haemorrhage, renal failure acute, retroperitoneal haematoma. Patient was hospitalized.

6423866-2 | Haematoma, Post Procedural Complication
on Oct 30, 2009 Male patient from UNITED STATES , 72 years of age, weighting 160.5 lb, was diagnosed with cardiovascular disorder, surgery (What is surgery?) and was treated with Enoxaparin (View Usage). Patient experienced the following unwanted or unexpected effects: haematoma, post procedural complication. Enoxaparin dosage: 60 Mg Other Sq. Patient was hospitalized.


6390616-8 | Renal Failure Acute
on Sep 29, 2009 Female patient from PORTUGAL , 68 years of age, weighting 163.1 lb, was treated with Enoxaparin (View Usage). Patient had the following side effects: renal failure acute. Enoxaparin dosage: . During the same period patient was treated with PERINDOPRIL (View Perindopril Review and Perindopril Label ), INSULIN (View Insulin Review and Insulin Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), PENTOXIFILINA (View Pentoxifilina Review and Pentoxifilina Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

6368428-0 | Hepatic Enzyme Increased
Patient was taking Enoxaparin (View Usage). After Enoxaparin was administered, patient had the following side effects: hepatic enzyme increased on Sep 17, 2009 from NETHERLANDS Additional patient health information: Male patient , 47 years of age, was diagnosed with deep vein thrombosis (What is deep vein thrombosis?) and. Enoxaparin dosage: . During the same period patient was treated with ACENOCOUMAROL (Dose: Unk) (View Acenocoumarol Review and Acenocoumarol Label ).

6361287-1 | Hepatic Enzyme Increased
Adverse event was reported on Sep 14, 2009 by a Male patient taking Enoxaparin (View Usage) (Dosage: Dose: Unk) was diagnosed with deep vein thrombosis (What is deep vein thrombosis?) and. Location: NETHERLANDS , 28 years of age, Patient experienced the following unwanted or unexpected effects: hepatic enzyme increased. During the same period patient was treated with ACENOCOUMAROL (Dose: Unk) (View Acenocoumarol Review and Acenocoumarol Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), DICLOFENAC SODIUM (View Diclofenac Sodium Review and Diclofenac Sodium Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ZALDIAR (Dose: Unk) (View Zaldiar Review and Zaldiar Label ).

5906017-X | Hepatocellular Injury
on Sep 26, 2008 Female patient from NORWAY , 63 years of age, weighting 191.8 lb, was diagnosed with hypertension, thrombosis prophylaxis, pruritus and was treated with Enoxaparin (View Usage). Patient had the following side effects: hepatocellular injury. Enoxaparin dosage: . During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), DICLOFENAC (View Diclofenac Review and Diclofenac Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ALBYL (View Albyl Review and Albyl Label ), CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ).

5714511-X | Cardiac Valve Replacement Complication, Dyspnoea, Mitral Valve Incompetence, Off Label Use, Pulmonary Oedema, Ventricular Dysfunction
on Apr 10, 2008 Female patient from UNITED KINGDOM , 31 years of age, was treated with Enoxaparin (View Usage). After Enoxaparin was administered, patient had the following side effects: cardiac valve replacement complication, dyspnoea, mitral valve incompetence, off label use, pulmonary oedema, ventricular dysfunction. Enoxaparin dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5661358-9 | Atrial Fibrillation, Atrial Tachycardia, Pulmonary Embolism
Patient was taking Enoxaparin (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), atrial tachycardia, pulmonary embolism (What is pulmonary embolism?) on Mar 05, 2008 from UNITED STATES Additional patient health information: Female patient , 66 years of age, was diagnosed with hypertension and. Enoxaparin dosage: . During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), HYDRODIURIL (View Hydrodiuril Review and Hydrodiuril Label ), FERGON (View Fergon Review and Fergon Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), REGULAR INSULIN (View Regular Insulin Review and Regular Insulin Label ), OS CAL D (View Os-cal D Review and Os-cal D Label ). Patient was hospitalized.

5643122-X | Atrial Fibrillation, Atrial Tachycardia, Pulmonary Embolism
Adverse event was reported on Feb 25, 2008 by a Female patient taking Enoxaparin (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: UNITED STATES , 66 years of age, Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), atrial tachycardia, pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), HYDRODIURIL (View Hydrodiuril Review and Hydrodiuril Label ), FERGON (View Fergon Review and Fergon Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), REGULAR INSULIN (View Regular Insulin Review and Regular Insulin Label ), OS CAL D (View Os-cal D Review and Os-cal D Label ). Patient was hospitalized.

5586543-6 | Cardiac Failure
on Jan 02, 2008 Male patient from KOREA, REPUBLIC OF , 65 years of age, was diagnosed with thrombosis prophylaxis and was treated with Enoxaparin (View Usage). After Enoxaparin was administered, patient had the following side effects: cardiac failure. Enoxaparin dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), HYDROXYCHLOROQUINE (View Hydroxychloroquine Review and Hydroxychloroquine Label ).

5585633-1 | Cardiac Arrest, Gastric Haemorrhage, Pulmonary Embolism
on Jan 07, 2008 Female patient from UNITED STATES , 67 years of age, was treated with Enoxaparin (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), gastric haemorrhage, pulmonary embolism (What is pulmonary embolism?). Enoxaparin dosage: . During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LORATADINE (View Loratadine Review and Loratadine Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), EPHEDRINE (View Ephedrine Review and Ephedrine Label ), MARCAINE /00330101/ (View Marcaine /00330101/ Review and Marcaine /00330101/ Label ).

5127610-0 | Balance Disorder, Brain Stem Infarction, Confusional State, Cough, Dyspnoea, Myocardial Infarction, Oedema Peripheral, Pulmonary Embolism
Patient was taking Enoxaparin (View Usage). Patient had the following side effects: balance disorder, brain stem infarction, confusional state, cough, dyspnoea, myocardial infarction, oedema peripheral, pulmonary embolism (What is pulmonary embolism?) on Jul 21, 2006 from BELGIUM Additional patient health information: Male patient , 75 years of age, was diagnosed with thrombosis prophylaxis, hypertension, analgesic effect, dyspnoea, fungal infection (What is fungal infection?), parkinson's disease (What is parkinson's disease?), gastric ulcer and. Enoxaparin dosage: . During the same period patient was treated with CO APROVEL (View Co-aprovel Review and Co-aprovel Label ), DAFALGAN (View Dafalgan Review and Dafalgan Label ), DUOVENT (View Duovent Review and Duovent Label ), EMCORETIC (View Emcoretic Review and Emcoretic Label ), LAMISIL (View Lamisil Review and Lamisil Label ), MYSOLINE (View Mysoline Review and Mysoline Label ), ZANTAC (View Zantac Review and Zantac Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ).

5120356-4 | Gastrointestinal Haemorrhage, Subdural Haematoma
Adverse event was reported on Oct 02, 2006 by a Male patient taking Enoxaparin (View Usage) (Dosage: 80 Mg Q 12h Sq) was diagnosed with portal vein thrombosis and. Location: UNITED STATES , 52 years of age, weighting 163.1 lb, After Enoxaparin was administered, patient had the following side effects: gastrointestinal haemorrhage, subdural haematoma. Patient was hospitalized.

5120339-4 | Injection Site Haemorrhage, International Normalised Ratio Decreased, Platelet Count Decreased
on Oct 02, 2006 Male patient from UNITED STATES , 74 years of age, was treated with Enoxaparin (View Usage). Patient experienced the following unwanted or unexpected effects: injection site haemorrhage, international normalised ratio decreased, platelet count decreased. Enoxaparin dosage: . Patient was hospitalized.

5060762-X | Intestinal Obstruction, Pancreatitis
on Jul 19, 2006 Female patient from FRANCE , 78 years of age, was diagnosed with thrombosis prophylaxis, cerebrovascular accident, arrhythmia (What is arrhythmia?), hypertension, urinary incontinence (What is urinary incontinence?) and was treated with Enoxaparin (View Usage). Patient had the following side effects: intestinal obstruction, pancreatitis. Enoxaparin dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), FLECAINIDE ACETATE (View Flecainide Acetate Review and Flecainide Acetate Label ), CIBACENE (View Cibacene Review and Cibacene Label ), ALPRESS (View Alpress Review and Alpress Label ), DETRUSITOL (View Detrusitol Review and Detrusitol Label ).

4887642-4 | Cryptogenic Organizing Pneumonia, Embolism, Haemoptysis, Intracardiac Thrombus, Pulmonary Alveolar Haemorrhage, Respiratory Failure
Patient was taking Enoxaparin (View Usage). After Enoxaparin was administered, patient had the following side effects: cryptogenic organizing pneumonia, embolism, haemoptysis, intracardiac thrombus, pulmonary alveolar haemorrhage, respiratory failure on Jan 09, 2006 from UNITED STATES Additional patient health information: Male patient , 66 years of age, weighting 156.5 lb, was diagnosed with acute myocardial infarction and. Enoxaparin dosage: . During the same period patient was treated with AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), ASPIRIN (Dose: Unk) (View Aspirin Review and Aspirin Label ), PLAVIX (Dose: Unk) (View Plavix Review and Plavix Label ), HEPARIN (Dose: Unk) (View Heparin Review and Heparin Label ). Patient was hospitalized.

4887640-0 | Bladder Neoplasm Surgery, Muscular Weakness, Myocardial Ischaemia
Adverse event was reported on Jan 09, 2006 by a Male patient taking Enoxaparin (View Usage) (Dosage: ) was diagnosed with angina unstable and. Location: NETHERLANDS , 88 years of age, weighting 158.7 lb, Patient experienced the following unwanted or unexpected effects: bladder neoplasm surgery, muscular weakness, myocardial ischaemia. During the same period patient was treated with ASPIRIN (Dose: Unk) (View Aspirin Review and Aspirin Label ), PRAVASTATIN (Dose: Unk) (View Pravastatin Review and Pravastatin Label ), ATENOLOL (Dose: Unk) (View Atenolol Review and Atenolol Label ), CORONARY VASODILATORS (Dose: Unk) (View Coronary Vasodilators Review and Coronary Vasodilators Label ), NEXIUM (Dose: Unk) (View Nexium Review and Nexium Label ), NIFEDIPINE (Dose: Unk) (View Nifedipine Review and Nifedipine Label ). Patient was hospitalized.

4887639-4 | Musculoskeletal Pain
on Jan 09, 2006 Female patient from ITALY , 65 years of age, weighting 154.3 lb, was diagnosed with angina unstable and was treated with Enoxaparin (View Usage). Patient had the following side effects: musculoskeletal pain. Enoxaparin dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), LOW MOLECULAR WEIGHT HEPARIN (View Low Molecular Weight Heparin Review and Low Molecular Weight Heparin Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ), NSAID'S (View Nsaid's Review and Nsaid's Label ), CORONARY VASODILATORS (View Coronary Vasodilators Review and Coronary Vasodilators Label ), ACE INHIBITOR NOS (View Ace Inhibitor Nos Review and Ace Inhibitor Nos Label ), SERUMLIPIDREDUCING AGENTS (View Serumlipidreducing Agents Review and Serumlipidreducing Agents Label ). Patient was hospitalized and became disabled.

4886076-6 | Abortion Spontaneous
on Jan 11, 2006 Female patient from ARGENTINA , 30 years of age, was diagnosed with antiphospholipid syndrome and was treated with Enoxaparin (View Usage). After Enoxaparin was administered, patient had the following side effects: abortion spontaneous. Enoxaparin dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ).

4886075-4 | Abortion Spontaneous, Hellp Syndrome, Hypersensitivity, Injection Site Joint Pain, Injection Site Swelling
Patient was taking Enoxaparin (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous, hellp syndrome, hypersensitivity, injection site joint pain, injection site swelling on Jan 11, 2006 from ARGENTINA Additional patient health information: Female patient , 26 years of age, was diagnosed with antiphospholipid syndrome and. Enoxaparin dosage: . During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

4843723-2 | Aspiration Joint, Joint Swelling, Platelet Count Increased, Red Blood Cell Count Decreased
Adverse event was reported on Jul 06, 2005 by a Female patient taking Enoxaparin (View Usage) (Dosage: ) was diagnosed with deep vein thrombosis (What is deep vein thrombosis?) and. Location: AUSTRALIA , 68 years of age, Patient had the following side effects: aspiration joint, joint swelling, platelet count increased, red blood cell count decreased. During the same period patient was treated with WARFARIN (View Warfarin Review and Warfarin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ). Patient was hospitalized.

4838600-7 | Cardiac Arrest, Hypotension, Intra-abdominal Haemorrhage
on Nov 23, 2005 Male patient from UNITED STATES , weighting 191.8 lb, was diagnosed with atrial fibrillation (What is atrial fibrillation?), post procedural complication and was treated with Enoxaparin (View Usage). After Enoxaparin was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), hypotension, intra-abdominal haemorrhage. Enoxaparin dosage: 40mg Q12h Sq.

4838160-0 | Erythema, International Normalised Ratio Decreased, Oedema Peripheral, Pain In Extremity, Skin Warm
on Nov 23, 2005 Male patient from UNITED STATES , weighting 273.4 lb, was diagnosed with deep vein thrombosis (What is deep vein thrombosis?) and was treated with Enoxaparin (View Usage). Patient experienced the following unwanted or unexpected effects: erythema, international normalised ratio decreased, oedema peripheral, pain in extremity, skin warm. Enoxaparin dosage: 150mg Sq Q24h. Patient was hospitalized.

4838041-2 | Blood Pressure Diastolic Decreased, Blood Pressure Systolic Increased, Extradural Haematoma, Urinary Retention
Patient was taking Enoxaparin (View Usage). Patient had the following side effects: blood pressure diastolic decreased, blood pressure systolic increased, extradural haematoma, urinary retention on Nov 14, 2005 from UNITED STATES Additional patient health information: Female patient , 85 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?), cardiac valve disease and. Enoxaparin dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

4838040-0 | Abdominal Compartment Syndrome, Abdominal Pain, Haemoglobin Decreased, Muscle Haemorrhage, Oliguria, Peritoneal Haemorrhage, Tachycardia
Adverse event was reported on Nov 14, 2005 by a Female patient taking Enoxaparin (View Usage) (Dosage: ) was diagnosed with international normalised ratio and. Location: TURKEY , 46 years of age, After Enoxaparin was administered, patient had the following side effects: abdominal compartment syndrome, abdominal pain (What is abdominal pain?), haemoglobin decreased, muscle haemorrhage, oliguria, peritoneal haemorrhage, tachycardia. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ).

4789538-5 | Blood Urine Present, International Normalised Ratio Increased
on Oct 05, 2005 Male patient from UNITED STATES , 80 years of age, weighting 200.0 lb, was diagnosed with deep vein thrombosis (What is deep vein thrombosis?), atrial fibrillation (What is atrial fibrillation?) and was treated with Enoxaparin (View Usage). Patient experienced the following unwanted or unexpected effects: blood urine present, international normalised ratio increased. Enoxaparin dosage: 70 Mg Sq Bid. During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

4661414-8 | Dyspnoea, Heparin-induced Thrombocytopenia
on May 11, 2005 Female patient from , 46 years of age, was treated with Enoxaparin (View Usage). Patient had the following side effects: dyspnoea, heparin-induced thrombocytopenia. Enoxaparin dosage: .

4608502-X | Neutropenia, Pneumonia
Patient was taking Enoxaparin (View Usage). After Enoxaparin was administered, patient had the following side effects: neutropenia, pneumonia (What is pneumonia?) on Feb 11, 2005 from Additional patient health information: Female patient , 95 years of age, weighting 92.59 lb, was diagnosed with infection (What is infection?), cardiac failure, pneumonia (What is pneumonia?) and. Enoxaparin dosage: . During the same period patient was treated with COVERSYL 4 MG (View Coversyl 4 Mg Review and Coversyl 4 Mg Label ), IMOVANE (View Imovane Review and Imovane Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), STABLON (View Stablon Review and Stablon Label ), TRANXENE (View Tranxene Review and Tranxene Label ), CLAFORAN (View Claforan Review and Claforan Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), CLAMOXYL (View Clamoxyl Review and Clamoxyl Label ).

4602585-9 | Circulatory Collapse, Dizziness, Skin Discolouration, Syncope
Adverse event was reported on Mar 02, 2005 by a Male patient taking Enoxaparin (View Usage) (Dosage: ) was diagnosed with deep vein thrombosis (What is deep vein thrombosis?), arthropathy and. Location: , 59 years of age, weighting 191.8 lb, Patient experienced the following unwanted or unexpected effects: circulatory collapse, dizziness (What is dizziness?), skin discolouration, syncope. During the same period patient was treated with GLUCOSAMINE (View Glucosamine Review and Glucosamine Label ), CHONDROITIN (View Chondroitin Review and Chondroitin Label ).

4598356-2 | Depressed Level Of Consciousness, Hypoxia, Pneumonia Aspiration, Respiratory Distress, Upper Gastrointestinal Haemorrhage
on Feb 25, 2005 Male patient from , 60 years of age, weighting 121.3 lb, was diagnosed with thrombosis prophylaxis and was treated with Enoxaparin (View Usage). Patient had the following side effects: depressed level of consciousness, hypoxia, pneumonia aspiration, respiratory distress, upper gastrointestinal haemorrhage. Enoxaparin dosage: . During the same period patient was treated with DEPLATT (View Deplatt Review and Deplatt Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), VITAMIN K (View Vitamin K Review and Vitamin K Label ), DOPAMINE (View Dopamine Review and Dopamine Label ), METROGYL (View Metrogyl Review and Metrogyl Label ), CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), PANTOCID (Dose Unit: Millilitre Per Hour) (View Pantocid Review and Pantocid Label ).

4588689-8 | Thrombocytopenia
on Feb 14, 2005 Female patient from , 73 years of age, weighting 169.8 lb, was diagnosed with peripheral vascular disorder and was treated with Enoxaparin (View Usage). After Enoxaparin was administered, patient had the following side effects: thrombocytopenia. Enoxaparin dosage: 70 Mg Sq Q 12h. During the same period patient was treated with PLAVIX (75 Mg Po Daily) (View Plavix Review and Plavix Label ), XALATAN OPHTH (View Xalatan Ophth Review and Xalatan Ophth Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), CORTEF (View Cortef Review and Cortef Label ), ZOCOR (View Zocor Review and Zocor Label ), NEXIUM (View Nexium Review and Nexium Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ). Patient was hospitalized.

4588528-5 | Neutropenia
Patient was taking Enoxaparin (View Usage). Patient experienced the following unwanted or unexpected effects: neutropenia on Feb 11, 2005 from Additional patient health information: Female patient , 84 years of age, weighting 121.3 lb, . Enoxaparin dosage: .

4588331-6 | Compartment Syndrome, Haematocrit Decreased, Haemorrhage
Adverse event was reported on Feb 15, 2005 by a Male patient taking Enoxaparin (View Usage) (Dosage: 80 Mg Sq Bid) was diagnosed with deep vein thrombosis (What is deep vein thrombosis?) and. Location: , 73 years of age, weighting 176.8 lb, Patient had the following side effects: compartment syndrome, haematocrit decreased, haemorrhage. During the same period patient was treated with WARFARIN SODIUM (7 Mg Daily) (View Warfarin Sodium Review and Warfarin Sodium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DOCUSATE (View Docusate Review and Docusate Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ), PIROXICAM (View Piroxicam Review and Piroxicam Label ). Patient was hospitalized.